‘My patients are extremely satisfied with the brand new TECNIS Multifocal lenses,’ stated Dr. Kerry Assil, medical director of the Assil Attention Institute in LA. ‘Many of them can easily read very easily, not only up close, but at intermediate distance as well, and in every lighting conditions. This improved eyesight following cataract surgery assists people live the energetic lives they need.’ The TECNIS Multifocal IOLs have already been well-studied. The FDA approval of the brand new TECNIS Multifocal +2.75D and +3.25D IOLS is based on a study of 445 people with cataracts. The results showed: More than 80 % of people reported having the ability to function comfortably without glasses at all distances 93 % of individuals reported they would have got the same IOL implanted again Patients had a mean visible acuity of 20/25 in both optical eye at near distances Patients had a mean visible acuity of 20/20 in both eyes at significantly distances Good vision was maintained in low lighting conditions..ABX464 is a novel, small molecule inhibiting HIV replication through an entirely new mechanism. For the very first time in the treating AIDS, this molecule could deliver a long lasting reduced amount of the viral load after a treatment of only a few weeks. In collaboration with the united team of Professor Jamal Tazi at the CNRS in Montpellier, France, ABIVAX designed ABX464 to result in a relevant improvement in HIV therapy clinically. ABX464 inhibits the biogenesis of viral RNA necessary for the replication of the HIV virus, a mechanism of action nothing you’ve seen prior explored.